Pharma Equity Group AS (OCSE:PEG) Other Operating Expense: kr8.12 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pharma Equity Group AS Other Operating Expense?

Pharma Equity Group AS OCSE:PEG +2.02% Other Operating Expense is kr8.12 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Pharma Equity Group AS's Other Operating Expense for the six months ended in Dec. 2025 was kr8.12 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was kr8.12 Mil.

Pharma Equity Group AS's quarterly Other Operating Expense declined from Dec. 2024 (kr16.19 Mil) to Jun. 2025 (kr-0.00 Mil) but then increased from Jun. 2025 (kr-0.00 Mil) to Dec. 2025 (kr8.12 Mil).

Pharma Equity Group AS's annual Other Operating Expense increased from Dec. 2023 (kr4.40 Mil) to Dec. 2024 (kr16.19 Mil) but then declined from Dec. 2024 (kr16.19 Mil) to Dec. 2025 (kr8.12 Mil).

Pharma Equity Group AS Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Pharma Equity Group AS's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group AS Other Operating Expense Chart

Pharma Equity Group AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.50 -0.00 4.40 16.19 8.12

Pharma Equity Group AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.40 0.00 16.19 -0.00 8.12

Pharma Equity Group AS Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr8.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr8.12 Mil mean?
Pharma Equity Group AS (OCSE:PEG) has a Other Operating Expense of kr8.12 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Pharma Equity Group AS and its competitors.
Is Pharma Equity Group AS's Other Operating Expense too high?
Pharma Equity Group AS's current Other Operating Expense is kr8.12 Mil.
How does Pharma Equity Group AS's Other Operating Expense compare to VRTX and REGN?
Pharma Equity Group AS's Other Operating Expense of kr8.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Pharma Equity Group AS and its competitors. Pharma Equity Group AS's current Other Operating Expense is kr8.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Equity Group AS stock overvalued right now?
Pharma Equity Group AS (OCSE:PEG) has a current Other Operating Expense of kr8.12 Mil. The current Other Operating Expense is kr8.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Pharma Equity Group AS (OCSE:PEG), the current Other Operating Expense is kr8.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharma Equity Group AS Business Description

Address Slotsmarken 12, 1.th, Horsholm, DNK, DK-2970
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .